Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04137289
Title A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim

esophagus adenocarcinoma


gallbladder carcinoma

gastric adenocarcinoma

pancreatic adenocarcinoma

colorectal adenocarcinoma


BI 905711

Age Groups: adult | senior
Covered Countries USA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Yale Cancer Center Recruiting New Haven Connecticut 06511 United States Details
Memorial Sloan-Kettering Cancer Center Recruiting New York New York 10022 United States Details
The University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
START South Texas Accelerated Research Therapeutics, LLC Recruiting San Antonio Texas 78229 United States Details
Brussels - UNIV Saint-Luc Recruiting Bruxelles 1200 Belgium Details
Beijing Cancer Hospital Active, not recruiting Beijing 100142 China Details
Universitätsklinikum Mannheim GmbH Recruiting Mannheim 68167 Germany Details
National Cancer Center Hospital East Recruiting Chiba, Kashiwa 277-8577 Japan Details
Hospital Vall d'Hebron Recruiting Barcelona 08035 Spain Details
*Shaded cells indicate that there was no data available from for the field